请使用支持JavaScript的浏览器! Bachem - Financial Performance-蚂蚁淘商城
新闻动态

Bachem - Financial Performance

  
  2025-05-10
  

Sales pass 300-million mark for the first time at 313.7 million CHFEBIT margin rises to 19.9%, EBITDA margin to 27.8%Net income up sharply to 54.2 million CHFInitial successes in oligonucleotide marketGrowth targets raised thanks to rising demandProposed dividend increase to 3.00 CHF per share

Bubendorf/Basel, March 13, 2020 – The Bachem Group (SIX: BANB) surpassed the 300 million CHF sales mark for the first time in fiscal year 2019. Sales rose for the ninth time in succession, hitting a new record of 313.7 million CHF (2018: 282.5 million CHF, +11.0%). Operating profit at the EBIT level rose dis-proportionately by 13.8% to 62.4 million CHF. At the EBITDA level, it came to 87.2 million CHF (previous year: 77.9 million CHF). The results lifted the EBIT margin to 19.9% and the EBITDA margin to 27.8%. Despite a sizeable foreign currency result of -1.6 million CHF (2018: +0.4 million CHF), Bachem achieved a 16.1% gain in net income to 54.2 million CHF.

... Read the full press release

本文链接: https://www.ebiomall.cn/b66-bachem/info-1529806680.html

免责声明 本文仅代表作者个人观点,与本网无关。其创作性以及文中陈述文字和内容未经本站证实,对本文以及其中全部或者部分内容、文字的真实性、完整性、及时性本站不做任何保证或承诺,请读者仅作参考,并请自行核实相关内容。
版权声明 未经蚂蚁淘授权不得转载、摘编或利用其他方式使用上述作品。已经经本网授权使用作品的,应该授权范围内使用,并注明“来源:蚂蚁淘”。违反上述声明者,本网将追究其相关法律责任。
没有了